Aspen Aerogels Q1 EPS $(0.02) Beats $(0.11) Estimate, Sales $94.50M Beat $75.00M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aspen Aerogels (NYSE:ASPN) reported Q1 EPS of $(0.02), surpassing the $(0.11) estimate, and sales of $94.50M, exceeding the $75.00M estimate. This represents significant improvements over the previous year, with a 91.67% decrease in losses and a 107.30% increase in sales.
May 01, 2024 | 9:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aspen Aerogels reported a significant beat on both EPS and sales estimates for Q1, with EPS at $(0.02) against an $(0.11) estimate and sales of $94.50M surpassing the $75.00M estimate.
Beating both EPS and sales estimates significantly, especially with such a large year-over-year growth in sales (107.30%) and a substantial reduction in losses (91.67%), is likely to be viewed positively by investors. This outperformance could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100